首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1676236

全球感染監測解決方案市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Infection Surveillance Solutions Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球感染監測解決方案市場規模預計將從 2024 年的 5.8709 億美元成長到 2033 年的 18.3445 億美元，在 2026 年至 2033 年的預測期內呈現強勁的 0.135% 的年複合成長率(CAGR)。

受醫療保健環境對有效感染控制和預防策略的需求不斷成長的推動，感染監測解決方案市場有望大幅成長。隨著全球醫院內感染（HAI）負擔不斷上升，醫療機構正在優先實施強大的監測系統來監測和管理感染爆發。這些解決方案使醫療保健提供者能夠收集、分析和報告感染率資料，促進及時介入並提高病人安全。資料分析、人工智慧和機器學習方面的創新正在增強感染監測系統的功能，實現即時監控和預測分析，從而可以在疫情升級之前識別潛在的疫情。

此外，對法規遵循和品質改進措施的日益重視正在影響感染監測解決方案市場。醫療保健組織越來越需要遵守監管機構制定的嚴格準則和報告標準，從而推動對確保合規性的全面監控解決方案的需求。此外，基於價值的護理模式的興起促使醫療保健提供者專注於改善患者治療結果並降低與感染相關的成本，進一步推動感染監測技術的採用。

此外，COVID-19 疫情凸顯了感染監測在管理公共衛生危機中的重要性。有效追蹤和報告傳染病的需求導致對監測技術的投資增加，不僅在醫院，而且在公共衛生機構。行動醫療應用程式和遠距醫療平台的整合也提高了感染監測解決方案的可近性和效率，使醫療保健提供者能夠即時監測感染並迅速應對新出現的威脅。總之，感染監測解決方案市場將實現強勁成長，其特點是技術進步、注重法規遵從性以及致力於改善病患安全和公共健康。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 9 章：感染監測解決方案公司的競爭格局

感染監測解決方案市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Becton

公司概況
公司收入
產品
最新動態

Dickinson And Company (BD)

公司概況
公司收入
產品
最新動態

Premier Inc.

公司概況
公司收入
產品
最新動態

Wolters Kluwer NV

公司概況
公司收入
產品
最新動態

Cerner Corporation (Oracle)

公司概況
公司收入
產品
最新動態

RLDatix

公司概況
公司收入
產品
最新動態

VigiLanz Corporation

公司概況
公司收入
產品
最新動態

GOJO Industries Inc.

公司概況
公司收入
產品
最新動態

Baxter International Inc.

公司概況
公司收入
產品
最新動態

BioMéRieux SA

公司概況
公司收入
產品
最新動態

IBM Corporation (Merative)

公司概況
公司收入
產品
最新動態

Epic Systems Corporation

公司概況
公司收入
產品
最新動態

Theradoc (Premier Inc.)

公司概況
公司收入
產品
最新動態

BioVigil Healthcare Systems Inc.

公司概況
公司收入
產品
最新動態

Ecolab Inc.

公司概況
公司收入
產品
最新動態

Asolva Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR112115391

Global Infection Surveillance Solutions Market size is anticipated to grow from USD 587.09 Million in 2024 to USD 1834.45 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 0.135% during the forecast period of 2026 to 2033.

The infection surveillance solutions market is poised for significant growth, driven by the increasing need for effective infection control and prevention strategies in healthcare settings. As the global burden of healthcare-associated infections (HAIs) continues to rise, healthcare facilities are prioritizing the implementation of robust surveillance systems to monitor and manage infection outbreaks. These solutions enable healthcare providers to collect, analyze, and report data on infection rates, facilitating timely interventions and improving patient safety. Innovations in data analytics, artificial intelligence, and machine learning are enhancing the capabilities of infection surveillance systems, allowing for real-time monitoring and predictive analytics that can identify potential outbreaks before they escalate.

Moreover, the growing emphasis on regulatory compliance and quality improvement initiatives is influencing the infection surveillance solutions market. Healthcare organizations are increasingly required to adhere to stringent guidelines and reporting standards set by regulatory bodies, driving the demand for comprehensive surveillance solutions that ensure compliance. Additionally, the rise of value-based care models is prompting healthcare providers to focus on improving patient outcomes and reducing costs associated with infections, further fueling the adoption of infection surveillance technologies.

Furthermore, the COVID-19 pandemic has underscored the importance of infection surveillance in managing public health crises. The need for effective tracking and reporting of infectious diseases has led to increased investments in surveillance technologies, not only in hospitals but also in public health agencies. The integration of mobile health applications and telehealth platforms is also enhancing the accessibility and efficiency of infection surveillance solutions, enabling healthcare providers to monitor infections in real-time and respond swiftly to emerging threats. In summary, the infection surveillance solutions market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to improving patient safety and public health.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Products and Services

Software
Services

By Infection Type

Surgical Site Infections
Blood Stream Infections
Urinary Tract Infections

By End User

Hospitals
Clinics
Ambulatory Surgical Centers
Other
COMPANIES PROFILED
Baxter
BD
STERIS
Getinge AB
Medtronic
Koninklijke Philips N.V.
Abbott
Medexter Healthcare
Asolva
GOJO Industries Inc
Wolters Kluwer N.V.
VigiLanz Corporation
RLDatix
Roper Technologies Inc
Health Outcomes Worldwide
OpGen Inc
Urovant Sciences and Premier
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INFECTION SURVEILLANCE SOLUTIONS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Products and Services
- 3.7.2 Market Attractiveness Analysis By Infection Type
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY PRODUCTS AND SERVICES

5.1. Overview By Products and Services
5.2. Historical and Forecast Data Analysis By Products and Services
5.3. Software Historic and Forecast Sales By Regions
5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY INFECTION TYPE

6.1. Overview By Infection Type
6.2. Historical and Forecast Data Analysis By Infection Type
6.3. Surgical Site Infections Historic and Forecast Sales By Regions
6.4. Blood Stream Infections Historic and Forecast Sales By Regions
6.5. Urinary Tract Infections Historic and Forecast Sales By Regions

7. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Clinics Historic and Forecast Sales By Regions
7.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions

8. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE INFECTION SURVEILLANCE SOLUTIONS COMPANIES

9.1. Infection Surveillance Solutions Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF INFECTION SURVEILLANCE SOLUTIONS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Becton
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Dickinson And Company (BD)
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Premier Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Wolters Kluwer N.V.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Cerner Corporation (Oracle)
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. RLDatix
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. VigiLanz Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. GOJO Industries Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Baxter International Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. BioMéRieux SA
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. IBM Corporation (Merative)
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Epic Systems Corporation
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Theradoc (Premier Inc.)
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. BioVigil Healthcare Systems Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Ecolab Inc.
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments
10.18. Asolva Inc
- 10.18.1 Company Overview
- 10.18.2 Company Revenue
- 10.18.3 Products
- 10.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Products and Services (USD MN)
Software Market Sales By Geography (USD MN)
Services Market Sales By Geography (USD MN)
Analysis By Infection Type (USD MN)
Surgical Site Infections Market Sales By Geography (USD MN)
Blood Stream Infections Market Sales By Geography (USD MN)
Urinary Tract Infections Market Sales By Geography (USD MN)
Analysis By End User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Clinics Market Sales By Geography (USD MN)
Ambulatory Surgical Centers Market Sales By Geography (USD MN)
Global Infection Surveillance Solutions Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Infection Surveillance Solutions Report
Market Research Process
Market Research Methodology
Global Infection Surveillance Solutions Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Products and Services
Market Attractiveness Analysis By Infection Type
Market Attractiveness Analysis By End User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Products and Services (USD MN)
Software Market Sales By Geography (USD MN)
Services Market Sales By Geography (USD MN)
Global Market Analysis By Infection Type (USD MN)
Surgical Site Infections Market Sales By Geography (USD MN)
Blood Stream Infections Market Sales By Geography (USD MN)
Urinary Tract Infections Market Sales By Geography (USD MN)
Global Market Analysis By End User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Clinics Market Sales By Geography (USD MN)
Ambulatory Surgical Centers Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.